Medpace Holdings Faces Securities Fraud Lawsuit Over Misrepresented Growth Outlook
Medpace Holdings Inc. (NASDAQ: MEDP) is facing a securities fraud lawsuit alleging the company misrepresented its growth outlook, leading to a significant drop in its stock price. The lawsuit covers purchases between April 22, 2025, and February 9, 2026, with investors potentially seeking to lead a class action. The stock fell 15.9% following the disclosure of a book-to-bill ratio below management's projections.
Tickers: $MEDP
Topics: book-to-bill ratio class action lawsuit financial reporting investor sentiment legal action stock price decline